mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.07 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.08 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |